Stay updated on Cabotegravir/Rilpivirine for Virologic Suppression Clinical Trial

Sign up to get notified when there's something new on the Cabotegravir/Rilpivirine for Virologic Suppression Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabotegravir/Rilpivirine for Virologic Suppression Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page now displays the clinical trial record, including its study details, outcome measures, publications, and supporting documents, instead of a 403 error.
    Difference
    100%
    Check dated 2026-11-10T22:45:48.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov site revision changed from v3.7.2 to v3.8.0. The study record remains inaccessible and displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-03T22:58:11.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    A general NIH website-transition notice appears above the ClinicalTrials.gov page, and the site revision changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T22:09:30.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    The site revision identifier changed from v3.7.0 to v3.7.1 on the 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-10-06T22:03:51.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the study record content, indicating access is blocked. This reflects a permission or access issue rather than a change in the underlying study data.
    Difference
    0.5%
    Check dated 2026-09-29T22:26:06.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the previous study record content with a generic error page. This blocks access to the NCT02938520 study details.
    Difference
    20%
    Check dated 2026-09-23T00:07:17.000Z thumbnail image

Stay in the know with updates to Cabotegravir/Rilpivirine for Virologic Suppression Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabotegravir/Rilpivirine for Virologic Suppression Clinical Trial page.